2011 High-Throughput Chemistry and Chemical Biology Gordon Research Seminar

2011年高通量化学与化学生物学戈登研究研讨会

• 批准号: 8189545
• 负责人: William Charles Krause Pomerantz
• 金额: $ 0.2万
• 依托单位: GORDON RESEARCH CONFERENCES
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-06-01 至 2012-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8189545
• 关键词: Address; Area; Biochemistry; Biological Process; Biology; Businesses; Chemicals; Chemistry; Collaborations; Coupled; Development; Discipline; Emerging Technologies; Environment; Evaluation; Feedback; Fertilization; Fostering; Goals; Government; Infusion procedures; Laboratories; Lead; Location; Mentorship; Methods; Molecular Bank; Molecular Biology; Participant; Pharmaceutical Chemistry; Positioning Attribute; Postdoctoral Fellow; Protein Engineering; Research; Research Personnel; Scientist; Screening procedure; Senior Scientist; Shapes; Site; Social Interaction; Students; Synthesis Chemistry; Talents; Technology; Time; Universities; Veterans; Writing; base; career; career development; college; design; drug discovery; frontier; graduate student; innovation; multidisciplinary; peer; posters; professor; programs; social; success; symposium

DESCRIPTION (provided by applicant): The Gordon Research Seminar (GRS) for High-Throughput Chemistry and Chemical Biology is a two-day conference designed to highlight the state-of-the-art advances in high-throughput methods for new screening technologies, high-quality molecular library development and cross-disciplinary chemical biology methods to unite the fields of synthetic chemistry and molecular biology. The goal of the GRS is to promote the research of early career scientists and develop the next leaders in the field of drug discovery. A successful scientific program, effective professional development, and synergistic interactions between early career scientists and senior researchers will be achieved through three specific aims: (1) Development of a cutting-edge scientific program presenting recent advances from the fields of high-throughput chemistry and chemical biology. (2) Creation of mentorship/career opportunities for early career scientist (3) Promotion of increased and sustained scientific discourse between GRS and GRC participants for fostering new innovative ideas in the area of drug discovery. The GRS features presentations by graduate students and postdoctoral researchers who are emerging leaders in their respective fields. Attendance of the GRS is capped at 50 participants. The intimate size and location of a GRS provides an environment for junior scientists to present their research to their immediate peers facilitates spirited scientific discourse and encourages participation throughout the duration of both the GRS and the Gordon Research Conference (GRC) to immediately follow. The two-day scientific program will include three scientific sessions and two poster sessions. Ten scientific talks will be presented with adequate time for discussion. All presentations will be by graduate students or postdoctoral researchers with the exception of a Keynote address by Professor Jim Wells, (UCSF), an internationally recognized leader in protein engineering, biochemistry, and drug discovery. To foster interactions with senior researchers, each session will be co-chaired by a senior research scientist and either a graduate student or postdoctoral researcher. Finally, a formal professional development/ career panel will conclude the conference. The panel will be composed of academics, industrial scientists and a postdoctoral research fellow. PUBLIC HEALTH RELEVANCE: Drug discovery benefits from a continual infusion of new ideas from many disciplines associated with this field specifically including the disciplines of high- throughput chemistry and chemical biology. Further, continued progress and sustained innovation for the field requires a continuous influx of new scientists contributing new ideas and becoming integrated into the field of drug discovery. The Gordon Research Seminar (GRS) provides such a forum, by bringing in graduate student and postdoctoral researchers to present the latest results in their respective fields, and encourages their scientific development through formal mentorship/career development components.

描述(由申请者提供)：高通量化学和化学生物学戈登研究研讨会(GRS)是一个为期两天的会议，旨在突出新筛选技术的高通量方法、高质量分子库开发和联合合成化学和分子生物学领域的跨学科化学生物学方法方面的最新进展。GRS的目标是促进早期职业科学家的研究，并培养药物发现领域的下一代领导者。成功的科学计划、有效的专业发展以及早期职业科学家和高级研究人员之间的协同互动将通过三个具体目标实现：(1)开发展示高通量化学和化学生物学领域最新进展的尖端科学计划。(2)为早期职业科学家创造导师/职业机会(3)促进GRS和GRC参与者之间更多和持续的科学讨论，以促进药物发现领域的新创新想法。GRS的特色是研究生和博士后研究人员的演讲，他们是各自领域的新兴领导者。GRS的出席人数上限为50人。GRS的亲密规模和位置为初级科学家提供了一个向他们的直属同行展示他们的研究的环境，促进了充满活力的科学讨论，并鼓励在GRS和戈登研究会议(GRC)期间的参与。为期两天的科学计划将包括三个科学会议和两个海报会议。十场科学讲座将有足够的时间进行讨论。所有演讲都将由研究生或博士后研究人员进行，除了加州大学旧金山分校(UCSF)教授吉姆·威尔斯(Jim Wells)的主旨演讲外，他是蛋白质工程、生物化学和药物发现领域的国际公认领导者。为了促进与高级研究人员的互动，每期会议将由一名高级研究科学家和一名研究生或博士后研究员共同主持。最后，一个正式的职业发展/职业发展小组将结束会议。该小组将由学者、工业科学家和一名博士后研究员组成。 与公共健康相关：药物发现得益于与该领域相关的许多学科的新思想的不断注入，特别是高通量化学和化学生物学学科。此外，该领域的持续进步和持续创新需要不断涌入贡献新想法的新科学家，并融入药物发现领域。戈登研究研讨会(GRS)提供了这样一个论坛，通过引入研究生和博士后研究人员来展示各自领域的最新成果，并通过正式的指导/职业发展部分鼓励他们的科学发展。